Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma

NCT00659360 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00659360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00659360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of AZD0530 in Recurrent or Metastatic Soft Tissue Sarcoma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
November 30, 2012
Enrollment
17 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adult fibrosarcoma, adult leiomyosarcoma, adult liposarcoma, adult malignant fibrous histiocytoma, adult rhabdomyosarcoma, dermatofibrosarcoma protuberans, endometrial stromal sarcoma, recurrent adult soft tissue sarcoma, recurrent uterine sarcoma, stage iii adult soft tissue sarcoma, stage iii uterine sarcoma, stage iv adult soft tissue sarcoma, stage iv uterine sarcoma, uterine carcinosarcoma, uterine leiomyosarcoma